DNAJC5 and malaria: To investigate the efficacy of virosome-formulated P. falciparum AMA-A- and CSP-derived peptides as a malaria vaccine, ten Tanzanian adults and 40 children aged between 5 and 9 years old living in a malaria-endemic region were immunized with one or two doses of the vaccine on days 0 and 90.